Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | AMGN | BMY | ||
| Company | Vertex Pharmaceutic | Amgen Inc | Bristol-Myers Squibb Company | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 483.00 | 316.16 | 55.14 | ||
| High | 497.00 | 319.18 | 55.80 | ||
| Low | 474.00 | 313.02 | 54.72 | ||
| Last | 496.46 | 318.73 | 55.90 | ||
| Change | +23.66 | +1.82 | +0.45 | ||
| % Change | +5.00% | +0.57% | +0.81% | ||
| Volume | 649,552 | 443,985 | 2,636,073 | ||
| 20-Day Average Volume | 1,016,524 | 1,669,063 | 8,374,987 | ||
| Previous Close | 472.80 | 316.91 | 55.45 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 478.59 | 319.64 | 53.22 | ||
| 20-Day Raw Stochastic | 86.77% | 38.62% | 87.52% | ||
| 20-Day Relative Strength | 58.53% | 46.52% | 63.07% | ||
| Weighted Alpha | +30.40 | +16.00 | +17.23 | ||
| Today's Opinion | 88% Buy | 8% Buy | 100% Buy | ||
| Previous Opinion | 24% Buy | 8% Buy | 88% Buy | ||
| Last Month's Opinion | 8% Sell | 24% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.90% since 10/29/24 | +0.57% since 10/29/24 | +5.89% since 10/29/24 | ||
| Low | 463.14 on 11/01/24 | 310.63 on 10/30/24 | 52.29 on 10/30/24 | ||
| High | 494.87 on 11/05/24 | 323.40 on 10/31/24 | 56.20 on 10/31/24 | ||
| 1-Month | |||||
| %Chg | +8.37% since 10/04/24 | -0.58% since 10/04/24 | +3.02% since 10/04/24 | ||
| Low | 447.70 on 10/07/24 | 310.63 on 10/30/24 | 51.31 on 10/15/24 | ||
| High | 499.09 on 10/17/24 | 329.17 on 10/11/24 | 56.20 on 10/31/24 | ||
| 3-Month | |||||
| %Chg | +3.46% since 08/05/24 | -2.28% since 08/05/24 | +16.81% since 08/05/24 | ||
| Low | 447.70 on 10/07/24 | 306.59 on 08/07/24 | 46.22 on 08/08/24 | ||
| High | 500.25 on 08/30/24 | 339.17 on 09/23/24 | 56.20 on 10/31/24 | ||
| 6-Month | |||||
| %Chg | +23.02% since 05/03/24 | +2.09% since 05/03/24 | +26.37% since 05/03/24 | ||
| Low | 394.03 on 05/07/24 | 295.30 on 06/13/24 | 39.35 on 07/05/24 | ||
| High | 510.64 on 08/01/24 | 346.85 on 07/25/24 | 56.20 on 10/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 122,030,624 | 170,284,928 | 112,462,416 | ||
| Shares Outstanding, K | 258,102 | 537,329 | 2,028,177 | ||
| Annual Sales | 9,869,200,000 | 28,190,000,000 | 45,006,000,000 | ||
| Annual Net Income | 3,619,600,000 | 6,717,000,000 | 8,025,000,000 | ||
| Last Quarter Sales | 2,645,600,000 | 8,503,000,000 | 11,892,000,000 | ||
| Last Quarter Net Income | -3,593,600,000 | 2,830,000,000 | 1,211,000,000 | ||
| 60-Month Beta | 0.39 | 0.60 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 4.38 on 11/04/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | ||
| Latest Earnings Date | 11/04/24 | 10/30/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 10/04/24 | ||
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 46.43 | ||